AgomAb Therapeutics NV (AGMB)
7.76
-0.64
(-7.62%)
USD |
NASDAQ |
Oct 28, 16:00
8.11
+0.35
(+4.51%)
After-Hours: 20:00
AgomAb Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2025 | 0.0096 |
| Date | Value |
|---|---|
| December 31, 2024 | 0.0082 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Cocrystal Pharma, Inc. | 1.284 |
| CNBX Pharmaceuticals, Inc. | -0.4388 |
| Invion Ltd. | -- |
| Arvinas, Inc. | 0.0146 |
| Fulcrum Therapeutics, Inc. | 0.017 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 180.52M |
| Total Liabilities (Quarterly) | 26.78M |
| Shareholders Equity (Quarterly) | 153.74M |